Amylyx Pharma Stock (NASDAQ: AMLX) stock price, news, charts, stock research, profile.
Open | $1.790 |
Close | $1.760 |
Volume / Avg. | 5.218M / 3.234M |
Day Range | 1.700 - 1.840 |
52 Wk Range | 1.760 - 30.500 |
Market Cap | $121.050M |
P/E Ratio | 2.543 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 20 |
Short Interest | 9.72% |
Days to Cover | 2.39 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Amylyx Pharma (NASDAQ: AMLX) through any online brokerage.
Other companies in Amylyx Pharma’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS), Rani Therapeutics Hldgs (NASDAQ:RANI), Marinus Pharma (NASDAQ:MRNS) and Alimera Sciences (NASDAQ:ALIM).
The latest price target for Amylyx Pharma (NASDAQ: AMLX) was reported by Baird on Thursday, April 11, 2024. The analyst firm set a price target for 3.00 expecting AMLX to rise to within 12 months (a possible 68.54% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Amylyx Pharma (NASDAQ: AMLX) is $1.78 last updated April 26, 2024 at 7:02 PM EDT.
There are no upcoming dividends for Amylyx Pharma.
Amylyx Pharma’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Amylyx Pharma.
Amylyx Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.